-
公开(公告)号:US10346588B2
公开(公告)日:2019-07-09
申请号:US15606909
申请日:2017-05-26
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
IPC: G01N33/48 , G06F19/00 , G16B50/00 , C12Q1/68 , C12Q1/6883 , C12Q1/689 , G16H50/20 , G16H20/10 , G16B99/00 , G16B5/00 , G06G7/58
Abstract: A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset, wherein the characterization is diagnostic of at least one of Crohn's disease, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), ulcerative colitis, and celiac disease; based upon the characterization, generating a therapy model configured to correct the immune microbial dysfunction; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
132.
公开(公告)号:US10340045B2
公开(公告)日:2019-07-02
申请号:US15644628
申请日:2017-07-07
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
Abstract: A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
133.
公开(公告)号:US10332635B2
公开(公告)日:2019-06-25
申请号:US15645049
申请日:2017-07-10
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
Abstract: A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
公开(公告)号:US10331857B2
公开(公告)日:2019-06-25
申请号:US15621152
申请日:2017-06-13
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
IPC: G01N33/48 , G06F19/00 , G16B50/00 , C12Q1/68 , C12Q1/6883 , C12Q1/689 , G16H50/20 , G16H20/10 , G16B99/00 , G16B5/00 , G06G7/58
Abstract: A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset, wherein the characterization is diagnostic of at least one of Crohn's disease, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), ulcerative colitis, and celiac disease; based upon the characterization, generating a therapy model configured to correct the immune microbial dysfunction; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
公开(公告)号:US10327642B2
公开(公告)日:2019-06-25
申请号:US15815636
申请日:2017-11-16
Applicant: uBiome, Inc
Inventor: Zachary Apte , Daniel Almonacid , Jessica Richman
IPC: G01N33/48 , A61B5/00 , C12Q1/689 , G06F19/00 , G16B40/00 , G16B50/00 , G16H50/20 , G16H50/80 , G06G7/58
Abstract: A method for at least one of characterizing, diagnosing, and treating a condition associated with microbiome-derived functional features in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
公开(公告)号:US10327641B2
公开(公告)日:2019-06-25
申请号:US15815365
申请日:2017-11-16
Applicant: uBiome, Inc
Inventor: Zachary Apte , Daniel Almonacid , Jessica Richman
IPC: G01N33/48 , A61B5/00 , C12Q1/689 , G06F19/00 , G16B40/00 , G16B50/00 , G16H50/20 , G16H50/80 , G06G7/58
Abstract: A method for at least one of characterizing, diagnosing, and treating a condition associated with microbiome-derived functional features in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
137.
公开(公告)号:US10325684B2
公开(公告)日:2019-06-18
申请号:US15645008
申请日:2017-07-10
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
Abstract: A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
138.
公开(公告)号:US10311973B2
公开(公告)日:2019-06-04
申请号:US15204707
申请日:2016-07-07
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Daniel Almonacid , Jessica Richman , Siavosh Rezvan Behbahani
Abstract: A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
139.
公开(公告)号:US10297351B2
公开(公告)日:2019-05-21
申请号:US15645034
申请日:2017-07-10
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
Abstract: A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
140.
公开(公告)号:US10290376B2
公开(公告)日:2019-05-14
申请号:US15645102
申请日:2017-07-10
Applicant: uBiome, Inc.
Inventor: Zachary Apte , Jessica Richman , Daniel Almonacid
Abstract: A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
-
-
-
-
-
-
-
-
-